Usefulness of serum cystatin C to determine the dose of vancomycin in critically ill patients

Journal of Pharmacy and Pharmacology

Volumn 62, Issue 7, 2010, Pages 901-907

  Suzuki, Akio ^a   Imanishi, Yoshinori ^a   Nakano, Shiho ^b   Niwa, Takashi ^a   Ohmori, Tomofumi ^a   Shirai, Kunihiro ^b   Yoshida, Shozo ^b   Furuta, Nobuyuki ^a   Takemura, Masao ^a   Ito, Hiroyasu ^a   Ieiri, Ichiro ^c   Seishima, Mitsuru ^a   Ogura, Shinji ^b   Itoh, Yoshinori ^a  

^a GIFU UNIVERSITY HOSPITAL   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

creatinine clearance; critically ill patients; cystatin C; loading dose; vancomycin

Indexed keywords

BIOLOGICAL MARKER; CREATININE; CYSTATIN C; VANCOMYCIN;

ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; CRITICALLY ILL PATIENT; FEMALE; HUMAN; KIDNEY FUNCTION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; CREATININE; CRITICAL ILLNESS; CYSTATIN C; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; VANCOMYCIN; YOUNG ADULT;

EID: 77953980861     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.62.07.0011     Document Type: Article

References (32)

1. Sorrell TC et al. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982 97 : 344 350.
2. Matzke GR et al. Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet 1986 11 : 257 282.
3. Rybak MJ et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 2009 49 : 325 327.
4. Rosner MH, Bolton WK. Renal function testing. Am J Kidney Dis 2006 47 : 174 183.
5. Stevens LA, Levey AS. Measurement of kidney function. Med Clin North Am 2005 89 : 457 473.
6. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16 : 31 41.
7. Kopple JD et al. Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int 1989 27 (Suppl S184 S194.
8. Levey AS et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130 : 461 470.
9. Imai E et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 2007 11 : 156 163. (Pubitemid 47012510)
10. Levey AS. Measurement of renal function in chronic renal disease. Kidney Int 1990 38 : 167 184.
11. Zamir O et al. Tumour necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms. Mediators Inflamm 1992 1 : 247 250.
12. Wray CJ et al. Catabolic response to stress and potential benefits of nutrition support. Nutrition 2002 18 : 971 977.
13. Grubb A et al. Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 1985 218 : 499 503. (Pubitemid 16147646)
14. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function: a review. Clin Chem Lab Med 1999 37 : 389 395.
15. Chantrel F et al. Comparison of cystatin C versus creatinine for detection of mild renal failure. Clin Nephrol 2000 54 : 374 381.
16. Krieser D et al. The relationship between serum creatinine, serum cystatin C and glomerular filtration rate in pediatric renal transplant recipients: a pilot study. Pediatr Transplant 2002 6 : 392 395.
17. Hojs R et al. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant 2006 21 : 1855 1862.
18. Roos JF et al. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children - a meta-analysis. Clin Biochem 2007 40 : 383 391.
19. Villa P et al. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care 2005 9 : R139 R143.
20. Wulkan R et al. Cystatin C unsuited to use as a marker of kidney function in the intensive care unit. Crit Care 2005 9 : 531 532.
21. Erlandsen EJ et al. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest 1999 59 : 1 8.
22. Hoek FJ et al. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003 18 : 2024 2031.
23. Rule AD et al. Larson TS/Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int 2006 69 : 399 405.
24. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight are known. Arch Intern Med 1916 17 : 863 871.
25. Yasuhara M et al. Population pharmacokinetics of vancomycin in Japanese adult patients. Ther Drug Monit 1998 20 : 139 148. (Pubitemid 28163195)
26. Delanaye P et al. Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units. Intensive Care Med 2004 30 : 980 983.
27. Risch L et al. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 2001 47 : 2055 2059.
28. Xu H et al. Assessment of glomerular filtration rate in renal transplant patients using serum cystatin C. Transplant Proc 2006 38 : 2006 2008.
29. Fricker M et al. Impact of thyroid dysfunction on serum cystatin C. Kidney Int 2003 63 : 1944 1947.
30. Wiesli P et al. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta 2003 338 : 87 90.
31. Tanaka A et al. Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function. Ther Drug Monit 2007 29 : 261 264.
32. Tanaka A et al. Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function. Antimicrob Agents Chemother 2010 54 : 778 782.